Pediatric Oncology Drugs

Oncology drugs are targeted to specific organs or locations in the body. Approval of new cancer drugs for pediatric patients generally occurs after their development and approval for treating adult cancers. As most drug development occurs in the industry setting, the relatively small market of pediatric oncology does not provide the financial incentives for companies to actively pursue pediatric oncology solutions. Larotrectinib is the first cancer drug to receive FDA breakthrough therapy designation for patients with a specific fusion of two genes in the cancer cell, no matter what cancer type. The research appears in The Lancet Oncology. To understand challenges in childhood cancer drug development better, how all of biomedical research is supported at the national and international levels needs to be considered. In the USA, approximately 60% of funding for biomedical research stems from the private biopharmaceutical sector.

    Related Conference of Pediatric Oncology Drugs

    March 28-29, 2024

    23rd Annual World Congress on Neonatology

    Dubai, UAE
    May 23-24, 2024

    37th World Pediatrics Conference

    Zurich, Switzerland
    May 27-28, 2024

    36th European Pediatrics Congress

    Amsterdam, Netherlands
    June 13-14, 2024

    3rd World Pediatric Conference

    Rome, Italy
    June 13-14, 2024

    22nd World Congress on Clinical Pediatrics

    Rome, Italy
    June 13-14, 2024

    32nd World Congress on Clinical Pediatrics

    Rome, Italy
    June 19-20, 2024

    9th Annual Summit on Pediatric Cardiology

    Rome, Italy
    July 18-19, 2024

    35th European Pediatrics Conference

    Paris, France
    August 19-20, 2024

    25th Annual World Congress on Pediatrics

    Zurich, Switzerland
    September 05-06, 2024

    24th World Congress on Pediatric Neurology and Neuropathology

    Brussels, Belgium
    September 16-17, 2024

    7th World Pediatric Infectious Disease Congress

    Zurich, Switzerland
    September 19-20, 2024

    25th World Congress on Pediatric Oncology and Cancer Care

    Paris, France
    September 19-20, 2024

    3rd International Conference on Neonatology

    Paris, France

    Pediatric Oncology Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in